Yahoo Finance

Needham analyst David Saxon raised the firm’s price target on SI-Bone (SIBN) to $24 from $20 and keeps a Buy rating on the shares. The company’s Q4 revenue was in line with its pre-announcement as procedure volume growth improved from the prior quarter and SI-Bone’s active surgeon base reached another record, the analyst tells investors in a research note. The management also guided to adjusted EBITDA profitability for 2025, the firm adds.

Discover the Best Stocks and Maximize Your Portfolio:

• See what stocks are receiving Strong Buy ratings from top-rated analysts.

• Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on SIBN:

• SI-Bone price target raised to $22 from $18 at Truist

• SI-Bone price target raised to $19 from $15 at Morgan Stanley

• SI-Bone’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating

• SI-Bone’s Strong Financial Performance and Promising Outlook Justifies Buy Rating and Raised Price Target

• SI-Bone: Strong Financial Performance and Strategic Positioning Justify Buy Rating